<DOC>
	<DOCNO>NCT02437409</DOCNO>
	<brief_summary>ARTESp prospective multicenter study pREset thrombectomy system ( phenox GmbH* Germany ) examine . The effectiveness , safety long-term success use pREset treat acute occlusion cerebral vessel analyze . *German : `` Gesellschaft mit beschränkter Haftung '' , limit liability company</brief_summary>
	<brief_title>Acute Recanalization Thrombo-Embolic Ischemic Stroke With pREset ( ARTESp )</brief_title>
	<detailed_description>ARTESp prospective multicenter study pREset thrombectomy system ( phenox GmbH Germany ) examine . The effectiveness , safety long-term success use pREset treat acute occlusion cerebral vessel analyze . In study market-approved , self-expandable stent retriever ( pREset , phenox GmbH , Germany ) use achieve direct flow recovery . The thrombectomy system unfold directly vessel occlusion . In second step , system thrombus pull back guide catheter . It plan enroll 100 patient age 18 85 year , NIHSS ( National Institutes Health Stroke Scale ) ≥ 8 ≤ 30 . The precondition study enrollment write consent patient legal representative fulfillment mention inclusion exclusion criterion . Pregnant woman exclude study participation.The clinical intervention accordance clinical standard care treatment patient population . The mRS ( Modified Rankin Scale ) day 30 , NIHSS day 90 imaging procedure day 90 may perform study site provide corresponds clinical standard study site .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Patient age ≥ 18 ≤ 85 year . Patients acuteonset stroke 06 hour time window cerebral onset symptom angiography TICI reperfusion ( Thrombolysis Cerebral Infarction ) value 0 1 least one major cerebral artery ( carotid artery , A. medium , anterior cerebral artery , basilar artery , vertebral artery , posterior cerebral artery ) . NIHSS ( National Institutes Health Stroke Scale ) ≥ 8 Signed Informed Consent patient / legal representative participate study . Pregnancy Demarcated infarcted area initial Cranial CT intracranial haemorrhage , Rapid improvement neurological symptom NIHSS &gt; 30 Anticoagulation warfarin INR ( international normalize ratio ) &gt; 3.0 , Platelets &lt; 30,000 , Glucose &lt; 50mg/dl , Life expectancy &lt; 90 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Ischemic , Acute</keyword>
</DOC>